Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)
Article in British Journal of Cancer (December 2023)
The most recent citing publications are shown below. View all 63 publications that cite this research output on Dimensions.
Article in British Journal of Cancer (December 2023)
Article in American Journal of Physiology - Cell Physiology (September 2023)
Article in Nephro-Urology Monthly (August 2023)